!

Test Heading

Learn More

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

About Us

Commercialization

Master
Heading

BCM Ventures: Maximizing Impact and Fostering Entrepreneurship

Content

The goal of Baylor College of Medicine Ventures (BCM Ventures), Baylor's commercialization team, is two-fold: to maximize the impact of the innovative enterprise at the College by supporting the development and commercialization of the Baylor’s intellectual property assets into products and services that benefit the public, and, to foster the development of a culture of entrepreneurship where commercialization is viewed as a natural extension of the College’s mission.

Heading

Commercialization Network at Baylor College of Medicine

Terms
Logo

Item Term
BCM Technologies, Inc. (BCMT)

Item Definition

BCMT is Baylor's wholly-owned for-profit venture development subsidiary corporation. Baylor College of Medicine Technologies, Inc., is the “start-up company team” that provides services around company formation and strategy, which includes securing company management and seeking investment opportunities for companies in their portfolio. BCMT coordinates the innovative “podco” program at the College, whereby companies are formed and operated in a very capital-efficient manner to determine if there is a sustainable business opportunity.

Dan L Duncan Institute for Clinical and Translational Research (ICTR)

Item Definition

The Dan L Duncan Institute for Clinical & Translational Research (ICTR) contributes important resources to support clinical translation of many of our promising candidate technologies.

Heading

Leadership

Content

See the commercialization leadership team at Baylor College of Medicine.

Heading

Industry and Investors

Content

Discover how our innovative, collaborative and entrepreneurial environment can assist you in fulfilling your mission. Find available technologies and learn about opportunities for you at Baylor College of Medicine.

Heading

Faculty Innovators

Content

Partnering with the BLG can help you maximize the impact of your research. Learn about our efficient and effective processes and systems for soliciting and managing invention disclosures and negotiating mutually beneficial agreements with industry partners.

Media Component
National Institute of Allergy and Infectious Diseases, National Institutes of Health
This is a colorized scanning electron micrograph of a T lymphocyte, a type of immune cell that can be 'trained' to fight cancer.
Heading

Companies merge, implement Baylor-developed cancer therapies

Content

Dr. Ann Leen, Dr. Juan Vera and their colleagues at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist have developed a novel therapy for cancer patients that harnesses the patient's own immune system to fight cancer in a natural way.

Heading

Research Collaboration to Focus on Neonatal Epilepsy

Content

Knopp Biosciences has entered a research collaboration with Baylor College of Medicine to develop new treatments for KCNQ2 neonatal encephalopathy.

Heading

Clinical Trial Updates

Content

Marker Therapeutics releases clinical updates in three Baylor College of Medicine-sponsored Phase I/II clinical trials using its MultiTAA T cell therapies, LAPP and MAPP.

Heading

Baylor graduate starts Speratum CR, brings discovery to cancer patients

Content

After graduation from Baylor College of Medicine, Dr. Christian Marín-Muller founded Speratum CR, S.A., a fast-growing biotechnology startup company, based in San José, Costa Rica.

Heading

The Estes Lab and ImmuCell Success Story

Content

After more than 20 years of research, discoveries from the lab of Dr. Mary Estes reached the point where they evolved into practical applications that improve the quality of life.